Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : CDK9 PROTAC 45
CAS No.: 2411021-01-5
Catalog No.: PC-21920Not For Human Use, Lab Use Only.
CDK9 PROTAC 45 is a highly potent, efficacious CDK9 PROTAC degrader, induces cell apoptosis in vitro and inhibits tumor growth in the MDA-MB-231 TNBC model.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 2 mg | $488 | In stock | |
| 5 mg | $758 | In stock | |
| 10 mg | Get quote | ||
| 25 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CDK9 PROTAC 45 is a highly potent, efficacious CDK9 PROTAC degrader, induces cell apoptosis in vitro and inhibits tumor growth in the MDA-MB-231 TNBC model.
CDK9 PROTAC 45 inhibits the growth of MDA-MB-468, MDA-MB-231, and BT-549 cells with IC50 values of 15.0, 13.6, and 3.9 nM, respectively.
CDK9 PROTAC 45 does not induce the degradation of other CDK proteins, including CDK1, CDK2, CDK4, CDK5, CDK6, and CDK7 within the concentration ranging from 100 to 500 nM in MDA-MB-231 cells.
CDK9 PROTAC 45 does not induce the degradation of GSPT1, which could induce degradation by certain CRBN-dependent PROTACs and molecule glues.
CDK9 PROTAC 45 demonstrates to specifically induce protein degradation of CDK9, rather than CDK7, resulting in the downregulation of MYC and a decrease of tumor cell proliferation in vivo.
CDK9 PROTAC 45 (2.5 or 5.0 mg/kg, i.p.) inhibits tumor growth in MDA-MB-231 CDX mice.
| M.Wt | 792.99 | |
| Formula | C43H56N10O5 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
4-(5-(2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pentyl)-N-(4-(((5-(((S)-1-hydroxybutan-2-yl)amino)-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)phenyl)piperazine-1-carboxamide |
|
1. Wei D, et al. J Med Chem. 2021 Oct 14;64(19):14822-14847.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
